European shares finished marginally higher on Monday, supported by defence stocks, while Novo Nordisk gained after data showed its weight-loss drug Wegovy delivers stronger heart-protective benefits than Eli Lilly's rival therapies. The pan-European STOXX 600 closed up 0.17% at 551.07, with gains led by the aerospace and defence index, which surged 2.1% to hover near a record high. Defence giants, Rolls-Royce Holdings, Rheinmetall and Hensoldt advanced between 2.8% and 4.5%. Gains followed a Financial Times report that European Commission President Ursula von der Leyen said Europe was...
Asia-Pacific markets mostly rose investors assessed the Shanghai Cooperation Organization meeting of leaders in Tianjin, with tariff uncertainty weighing on sentiment. This comes after a U.S. federal appeals court on Friday ruled that most of President Donald Trump's global tariffs are illegal. Japan's Nikkei 225 rose 0.31%, while the broader Topix index added 0.28%. Over in South Korea, the Kospi index increased by 0.45%, while the small-cap Kosdaq moved up 0.14%. The country's consumer price index rose 1.7% in August from the year before, after increasing by 2.1% the month before. This...
The Nikkei 225 Index rose 0.4% to around 42,350, while the broader Topix Index added 0.3% to 3,072 on Tuesday, with Japanese shares snapping a two-day losing streak as risk sentiment improved. Investors weighed the global trade outlook after a US federal appeals court ruled that most of President Donald Trump's tariffs were unlawful, giving the administration until October 14 to appeal to the US Supreme Court. Domestically, attention turned to upcoming wage data that could shape monetary policy direction. Bank of Japan Governor Kazuo Ueda recently said wages are set to rise further amid a...